Tumor necrosis factor (TNF) ? is a pleiotropic cytokine that induces cellular responses including proliferation, production of inflammatory mediators, and cell death and plays a major role in the pathophysiology of shock, inflammation, and the wasting syndrome. The initial period of this grant focused on the role of TNF? in inhibiting Type I collagen gene expression and the effect of TNF? on stimulating collagenase-1 gene expression with the net result of inhibiting fibrosis. However, we have subsequently discovered that TNF1 has a wide variety of effects on wound healing, including the induction of apoptosis in parenchymal cells, the induction of JNK with subsequent phosphorylation of Mcl-1 and other targets of apoptosis, the induction of reactive oxygen species, and the induction of the profribrogenic cytokine TGF?. Therefore, the current application will study hepatic fibrosis as a model of wound healing and address the following four specific aims: 1. To determine the role of the 5'Stem Loop of collagen ?1(I) mRNA in fibrosis. 2. To determine the role of TNF? and its receptor signaling in hepatic fibrosis. 3. To investigate how TNF1/TNFR-induced NFkB and JNK activation is coordinated by NOX derived ROS in HSC. 4. To assess the role of TNF1 induced JNK activation on hepatocyte apoptosis.

Public Health Relevance

Tumor necrosis factor (TNF)? is a multifunctional cytokine that is induced during inflammation and wound healing. TNF? has both anti-fibrotic effects on Type I collagen and pro-fibrotic effects on activating myofibroblasts. This proposal uses the wound healing model of hepatic fibrosis to assess how TNF? modulates wound healing through different signal transduction pathways in the whole organism and in specific hepatic cell populations.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Somers, Scott D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
Internal Medicine/Medicine
Schools of Medicine
La Jolla
United States
Zip Code
Liu, Cheng; Chen, Xiaorong; Yang, Ling et al. (2014) Transcriptional repression of the transforming growth factor ? (TGF-?) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor ?B (NF-?B) p50 enhances TGF-? signaling in hepatic stellate cells. J Biol Chem 289:7082-91
Iwaisako, Keiko; Jiang, Chunyan; Zhang, Mingjun et al. (2014) Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A 111:E3297-305
Schnabl, Bernd; Brenner, David A (2013) Fibroblast growth factor inducible 14 as potential target in patients with alcoholic hepatitis. Gut 62:335-6
Miura, Kouichi; Yang, Ling; van Rooijen, Nico et al. (2013) Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 57:577-89
Madsen, Daniel H; Leonard, Daniel; Masedunskas, Andrius et al. (2013) M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway. J Cell Biol 202:951-66
Nelson, David R; Teckman, Jeffrey; Di Bisceglie, Adrian M et al. (2012) Diagnosis and management of patients with ?1-antitrypsin (A1AT) deficiency. Clin Gastroenterol Hepatol 10:575-80
Iwaisako, Keiko; Brenner, David A; Kisseleva, Tatiana (2012) What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 27 Suppl 2:65-8
Osawa, Yosuke; Seki, Ekihiro; Kodama, Yuzo et al. (2011) Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression. FASEB J 25:1133-44
Gao, Bin; Seki, Ekihiro; Brenner, David A et al. (2011) Innate immunity in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 300:G516-25
Scholten, David; Reichart, Donna; Paik, Yong Han et al. (2011) Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 179:189-98

Showing the most recent 10 out of 92 publications